Home › Funds › Long Road Investment Counsel, LLC › ABT

Long Road Investment Counsel, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Long Road Investment Counsel, LLC reported holding 12,085 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.47% of its reported portfolio and ranking #43 among its reported holdings. Long Road Investment Counsel, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)12.09K sh
Reported value held$1.19M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Long Road Investment Counsel, LLC's ABT position evolved

Long Road Investment Counsel, LLC first disclosed a stake in ABT in Q3 2023 at 12,970 shares (US$1.3M). The position peaked in Q2 2025 at 13,805 shares, worth US$1.9M. Across 13 filings, Long Road Investment Counsel, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 12,085 shares valued at US$1.2M — a reduction of -1,400 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.97K $1.26M New
Q4 2023 12.97K $1.47M Hold
Q1 2024 12.97K $1.47M Hold
Q2 2024 12.97K $1.35M Hold
Q3 2024 12.97K $1.48M Hold
Q4 2024 12.77K $1.44M Reduce
Q1 2025 14.07K $1.87M Add
Q2 2025 13.80K $1.88M Reduce
Q3 2025 13.80K $1.85M Hold
Q4 2025 12.02K $1.51M Reduce
Q1 2026 13.54K $1.39M Add
Q2 2026 13.48K $1.22M Hold
Q3 2026 12.09K $1.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Long Road Investment Counsel, LLC held ABT?

Long Road Investment Counsel, LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Long Road Investment Counsel, LLC's current position in ABT?

As of Q3 2026, Long Road Investment Counsel, LLC holds 12.09K shares of ABT (ABBOTT LABORATORIES), valued at $1.19M, representing 0.47% of its reported portfolio and ranking #43.

Has Long Road Investment Counsel, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Long Road Investment Counsel, LLC reduced its position in ABT. The position peaked in Q2 2025 at 13.80K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.